Renoprotective effect of losartan in comparison to amlodipine in hypertensive patients with advanced IgA nephropathy.

被引:0
|
作者
Kawamura, T
Iino, Y
Kawaguchi, Y
机构
[1] Jikei Univ, Sch Med, Dept Med, Div Nephrol & Hypertens, Tokyo, Japan
[2] Nippon Med Coll, Dept Med 2, Div Nephrol, Tokyo 113, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:753A / 753A
页数:1
相关论文
共 50 条
  • [31] Saracatinib, a Src kinase inhibitor, enhances the renoprotective effect of metformin and losartan in diabetic nephropathy
    Khodir, Suzan A.
    Sweed, Eman M.
    Kora, Mona A.
    Zaki, Nader G.
    Amer, Ghada S.
    Ameen, Omnia
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2025,
  • [32] Comparison of the Efficacy and Safety of Fixed-Dose Amlodipine/Losartan and Losartan in Hypertensive Patients Inadequately Controlled with Losartan A Randomized, Double-Blind, Multicenter Study
    Hong, Bum-Kee
    Park, Chang Gyu
    Kim, Ki Sik
    Yoon, Myeong Ho
    Yoon, Ho Joong
    Yoon, Jeong Han
    Yang, Joo Young
    Choi, Young Jin
    Cho, Seung Yun
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (03) : 189 - 195
  • [33] Effects of losartan and amlodipine on macroalbuminuria and 24-H blood pressure in hypertensive type 2 diabetic patients with overt nephropathy
    Yasuda, G
    Ando, D
    Masuda, S
    Hirawa, N
    Umemura, S
    Tochikubo, O
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 138A - 139A
  • [34] Effects of losartan and amlodipine on urinary albumin excretion and ambulatory blood pressure in hypertensive type 2 diabetic patients with overt nephropathy
    Yasuda, G
    Ando, D
    Hirawa, N
    Umemura, S
    Tochikubo, O
    DIABETES CARE, 2005, 28 (08) : 1862 - 1868
  • [35] Prospective and randomized study of the antihypertensive effect of 3 antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients
    Lin, SL
    Wu, SC
    Liu, CP
    JOURNAL OF HYPERTENSION, 2005, 23 : S116 - S116
  • [36] Magnesium lithospermate B ameliorates diabetic nephropathy in OLETF rats: Comparison with losartan and amlodipine
    Kan, Eun Seok
    Lee, Geun Taek
    Kim, Beom Seok
    Kim, So Hun
    Hur, Kyu Yeon
    Lee, Hyun Joo
    Han, Seung Jin
    Kang, Shin Ae
    Ahn, Chul Woo
    Ha, Hunjoo
    Jung, Mankil
    Li, Hari
    Cha, Bong Soo
    Lee, Hyun Chul
    DIABETES, 2006, 55 : A180 - A180
  • [37] Effect of the combination therapy with Losartan plus hydrochlorothiazide in hypertensive patients - Efficacy of the switching from amlodipine monotherapy
    Geshi, E
    Suzuki, H
    Koba, S
    Katagiri, T
    JOURNAL OF HYPERTENSION, 2005, 23 : S377 - S377
  • [38] Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine
    Fogari, Roberto
    Mugellini, Amedeo
    Preti, Paola
    Zoppi, Annalisa
    Derosa, Giuseppe
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 87 - 93
  • [39] EFFECT OF LOSARTAN IN COMBINATION WITH AMLODIPINE OR HYDROCHLOROTHIAZIDE ON MICROALBUMINURIA PREDICTS REGRESSION OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS
    Bilchenko, O.
    Bilchenko, A.
    JOURNAL OF HYPERTENSION, 2016, 34 : E278 - E279
  • [40] Renoprotective effect of dual blockade of the renin-angiotensin system(RAS) in type 2 diabetic patients with diabetic nephropathy.
    Rossing, K
    Christensen, PK
    Jenson, BR
    Parving, HH
    DIABETOLOGIA, 2001, 44 : A35 - A35